PD-L1 expression in penile cancer: a new frontier for immune checkpoint inhibitors?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-L1 expression in penile cancer: a new frontier for immune checkpoint inhibitors?

Published:2016-09 Issue:9 Volume:27 Page:1658-1659
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Al-Ahmadie H.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/9/1658/6680061/mdw268.pdf

Reference25 articles.

1. Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches;Udager;Ann Oncol,2016

2. Penile cancer;Micali;J Am Acad Dermatol,2006

3. EAU guidelines on penile cancer: 2014 update;Hakenberg;Eur Urol,2015

4. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion;Dong;Nat Med,2002

5. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance;Marincola;Adv Immunol,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Natural Medicinal Plants Active Ingredients in Oral Squamous Cell Carcinoma;Chinese Journal of Integrative Medicine;2024-04-12

2. The peri- and intratumoral immune cell infiltrate and PD-L1 status in invasive squamous cell carcinomas of the penis;Clinical and Translational Oncology;2021-08-27

3. Triptolide suppresses oral cancer cell PD-L1 expression in the interferon-γ-modulated microenvironment in vitro, in vivo, and in clinical patients;Biomedicine & Pharmacotherapy;2021-01

4. Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives;Current Drug Metabolism;2017-10-16

5. Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma;European Urology Focus;2017-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3